Dry single-stage method of sodium tripolyphosphate production – technological and economic assessment

The study presents a technology of sodium tripolyphosphate (STPP) production with the use of a dry, single-stage method. The reacting substrates (concentrated wet-process phosphoric acid - WPPA and solid Na2CO3 ) are mixed with a recycled final product (STPP) in a mixer, then a „quasi-dry” mixture is calcined in a rotary kiln. Thanks to that, some stages of a classic method of STPP production are eliminated: one of the two-stage neutralization of the phosphoric acid with sodium carbonate at temperature ~80°C, filtration of the neutralised solution and its evaporation, as well as the stage of drying a solution of mono- and di-sodium orthophosphate in a spray dryer. According to the presented technical and economical analysis, the costs of STPP production using a single-stage dry method can be 10% lower compared to the classic method

From Latent Tuberculosis Infection to Tuberculosis. News in Diagnosticsb (QuantiFERON-Plus)

It is estimated that one third of the world’s population have latent tuberculosis infection and that this is a significant reservoir for future tuberculosis cases. Most cases occur within two years following initial infection. The identification of individuals with latent tuberculosis infection is difficult due to the lack of an ideal diagnostic assay and incomplete understanding of latent infection. Currently, there are three tests: the oldest tuberculin skin test, T-SPOT.TB and the latest QuantiFERON-Plus for the detection of Mycobacterium tuberculosis infec­tion. The interpretation of the test results must be used in the conjunction with a patient’s epidemiological history, risk assessment, current clinical status, radiography and microbiological methods to ensure accurate diagnosis

Molecular epidemiology of MRSA in 13 ICUs from eight European countries

International audienc

A decade of invasive meningococcal disease surveillance in Poland.

Neisseria meningitidis is a leading etiologic agent of severe invasive disease. The objective of the study was to characterise invasive meningococcal disease (IMD) epidemiology in Poland during the last decade, based on laboratory confirmed cases.The study encompassed all invasive meningococci collected between 2002 and 2011 in the National Reference Centre for Bacterial Meningitis. The isolates were re-identified and characterised by susceptibility testing, MLST analysis, porA and fetA sequencing. A PCR technique was used for meningococcal identification directly from clinical materials.In the period studied, 1936 cases of IMD were confirmed, including 75.6% identified by culture. Seven IMD outbreaks, affecting mostly adolescents, were reported; all were caused by serogroup C meningococci of ST-11. The highest incidence was observed among children under one year of age (15.71/100,000 in 2011). The general case fatality rate in the years 2010-2011 was 10.0%. Meningococci of serogroup B, C, Y and W-135 were responsible for 48.8%, 36.6%, 1.2% and 1.2% of cases, respectively. All isolates were susceptible to third generation cephalosporins, chloramphenicol, ciprofloxacin, and 84.2% were susceptible to penicillin. MLST analysis (2009-2011) revealed that among serogroup B isolates the most represented were clonal complexes (CC) ST-32CC, ST-18CC, ST-41/44CC, ST-213CC and ST-269CC, and among serogroup C: ST-103CC, ST-41/44CC and ST-11CC.The detection of IMD in Poland has changed over time, but observed increase in the incidence of the disease was mostly attributed to changes in the surveillance system including an expanded case definition and inclusion of data from non-culture diagnostics